+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cystic Fibrosis Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4770335
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • AbbVie Inc.
  • Allergan plc
  • AstraZeneca plc
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • Novartis International AG
  • MORE
The report on the global cystic fibrosis (CF) market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global cystic fibrosis market to grow with a CAGR of 16.6% over the forecast period from 2019-2025. The study on cystic fibrosis market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on cystic fibrosis market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cystic fibrosis market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cystic fibrosis market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Growing prevalence of cystic fibrosis diseases
  • Improvements in screening and treatments
2) Restraints
  • The high cost of treatment
3) Opportunities
  • Increasing global awareness for cystic fibrosis therapy,
  • Technological advancements in the R&D
Research Methodology
A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the Publisher
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global cystic fibrosis market is segmented on the basis of drug class, and route of administration.

The Global Cystic fibrosis Market by Drug Class
  • CFTR Modulators
  • Mucolytics
  • Pancreatic Enzyme Supplements
  • Bronchodilators
  • Other Drug Classes
The Global Cystic fibrosis Market by Route of Administration
  • Inhaled Drugs
  • Oral Drugs
Company Profiles
The companies covered in the report include
  • Alcresta Therapeutics, Inc.
  • AstraZeneca plc
  • Teva Pharmaceutical Industries
  • Allergan plc
  • Advanced Inhalation Therapies (AIT) Ltd.
  • F. Hoffmann-La Roche AG
  • Novartis International AG
  • Gilead Sciences, Inc.
  • Vertex Pharmaceuticals, Inc.
  • AbbVie Inc.
  • Other Companies
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the cystic fibrosis market.
2. Complete coverage of all the segments in the cystic fibrosis market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global cystic fibrosis market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie Inc.
  • Allergan plc
  • AstraZeneca plc
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • Novartis International AG
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Cystic Fibrosis Market Highlights
2.2. Cystic Fibrosis Market Projection
2.3. Cystic Fibrosis Market Regional Highlights

3. Global Cystic Fibrosis Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Drug Class
3.4.2. IGR-Growth Matrix Analysis by Route of Administration
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Cystic Fibrosis Market

4. Cystic Fibrosis Market Macro Indicator Analysis

5. Global Cystic Fibrosis Market by Drug Class
5.1. CFTR Modulators
5.2. Mucolytic
5.3. Pancreatic Enzyme Supplements
5.4. Bronchodilators
5.5. Other Drug Classes

6. Global Cystic Fibrosis Market by Route of Administration
6.1. Inhaled Drugs
6.2. Oral Drugs

7. Global Cystic Fibrosis Market by Region 2019-2025
7.1. North America
7.1.1. North America Cystic Fibrosis Market by Drug Class
7.1.2. North America Cystic Fibrosis Market by Route of Administration
7.1.3. North America Cystic Fibrosis Market by Country
7.2. Europe
7.2.1. Europe Cystic Fibrosis Market by Drug Class
7.2.2. Europe Cystic Fibrosis Market by Route of Administration
7.2.3. Europe Cystic Fibrosis Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Cystic Fibrosis Market by Drug Class
7.3.2. Asia-Pacific Cystic Fibrosis Market by Route of Administration
7.3.3. Asia-Pacific Cystic Fibrosis Market by Country
7.4. RoW
7.4.1. RoW Cystic Fibrosis Market by Drug Class
7.4.2. RoW Cystic Fibrosis Market by Route of Administration
7.4.3. RoW Cystic Fibrosis Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Cystic Fibrosis Market
8.2. Companies Profiles
8.2.1. Alcresta Therapeutics, Inc.
8.2.2. AstraZeneca plc
8.2.3. Teva Pharmaceutical Industries
8.2.4. Allergan plc
8.2.5. Advanced Inhalation Therapies (AIT) Ltd.
8.2.6. F. Hoffmann-La Roche AG
8.2.7. Novartis International AG
8.2.8. Gilead Sciences, Inc.
8.2.9. Vertex Pharmaceuticals, Inc.
8.2.10. AbbVie Inc.
8.2.11. Other Companies

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Alcresta Therapeutics, Inc.
  • AstraZeneca plc
  • Teva Pharmaceutical Industries
  • Allergan plc
  • Advanced Inhalation Therapies (AIT) Ltd.
  • F. Hoffmann-La Roche AG
  • Novartis International AG
  • Gilead Sciences, Inc.
  • Vertex Pharmaceuticals, Inc.
  • AbbVie Inc.
Note: Product cover images may vary from those shown
Adroll
adroll